Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126091791 | 12609179 | 1 | I | 20160701 | 20160727 | 20160801 | 20160801 | EXP | FR-ROCHE-1804377 | ROCHE | 51.00 | YR | F | Y | 0.00000 | 20160801 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126091791 | 12609179 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | 600 | MG | SOLUTION FOR INFUSION | /cycle | ||||||
| 126091791 | 12609179 | 2 | SS | IFOSFAMIDE EG | IFOSFAMIDE | 1 | Intravenous (not otherwise specified) | U | 6D282E6 | 0 | 8000 | MG | /cycle | ||||||
| 126091791 | 12609179 | 3 | SS | ETOPOSIDE MYLAN | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | U | 0 | 160 | MG | /cycle | |||||||
| 126091791 | 12609179 | 4 | SS | DEXAMETHASONE MYLAN | DEXAMETHASONE | 1 | Oral | U | 0 | 40 | MG | ||||||||
| 126091791 | 12609179 | 5 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | Unknown | 1-0-0 | 0 | 75 | UG | ||||||||
| 126091791 | 12609179 | 6 | C | INIPOMP | PANTOPRAZOLE SODIUM | 1 | Unknown | 0-0-1 | 0 | 40 | MG | ||||||||
| 126091791 | 12609179 | 7 | C | PROGRAF | TACROLIMUSTACROLIMUS ANHYDROUS | 1 | Unknown | 1.5-0-1 | 0 | 1 | MG | ||||||||
| 126091791 | 12609179 | 8 | C | DIFFU K | POTASSIUM CHLORIDE | 1 | Unknown | 2-0-2 | 0 | 600 | MG | ||||||||
| 126091791 | 12609179 | 9 | C | ZELITREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Unknown | 1-0-1 | 0 | 500 | MG | ||||||||
| 126091791 | 12609179 | 10 | C | DUPHALAC (FRANCE) | LACTULOSE | 1 | Unknown | 1 TO 2 BAG/DAY | 0 | ||||||||||
| 126091791 | 12609179 | 11 | C | DAFALGAN CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Unknown | UNTIL 4 TABLETS/DAY IF NECESSARY | 0 | 1 | DF | ||||||||
| 126091791 | 12609179 | 12 | C | DOLIPRANE | ACETAMINOPHEN | 1 | Unknown | UNTIL 4 TABLETS/DAY IF NECESSARY | 0 | 500 | MG | ||||||||
| 126091791 | 12609179 | 13 | C | LYRICA | PREGABALIN | 1 | Unknown | 1-0-0 | 0 | 25 | MG | ||||||||
| 126091791 | 12609179 | 14 | C | BICARBONATE | BICARBONATE ION | 1 | Buccal | MOUTHWASH | 0 | ||||||||||
| 126091791 | 12609179 | 15 | C | FUNGIZONE | AMPHOTERICIN B | 1 | Buccal | MOUTHWASH | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126091791 | 12609179 | 1 | B-cell lymphoma |
| 126091791 | 12609179 | 2 | B-cell lymphoma |
| 126091791 | 12609179 | 3 | B-cell lymphoma |
| 126091791 | 12609179 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126091791 | 12609179 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126091791 | 12609179 | Encephalopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126091791 | 12609179 | 1 | 20160517 | 20160629 | 0 | |
| 126091791 | 12609179 | 2 | 20160517 | 20160629 | 0 | |
| 126091791 | 12609179 | 3 | 20160517 | 20160629 | 0 | |
| 126091791 | 12609179 | 4 | 20160517 | 20160629 | 0 |